首页> 外国专利> PHARMACEUTICAL COMPOSITION FOR TREATMENT OF MATABOLIC SYNDROME COMPRISING COMPOUNDS RHAT STIMULATE AN INCREASE IN CENTRAL DOPAMINERGIC NEURONAL ACTIVITY AND DECREASE IN CENTRAL NORADRENERGIC NEURONAL ACTIVITY

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF MATABOLIC SYNDROME COMPRISING COMPOUNDS RHAT STIMULATE AN INCREASE IN CENTRAL DOPAMINERGIC NEURONAL ACTIVITY AND DECREASE IN CENTRAL NORADRENERGIC NEURONAL ACTIVITY

机译：药物组合物代谢综合征的治疗，引起中枢多巴胺能神经活性的增加和中枢肾上腺素能神经活性的降低

页面导航

摘要
著录项
相似文献

摘要

The present invention is directed to a method for treating a patient suffering from the metabolic syndrome, Type 2 diabetes, obesity, or prediabetes, comprising the step of increasing the ratio of dopaminergic neuronal to noradrenergic neuronal activity within the central nervous system and particularly the hypothalamus of the central nervous system of the patient.

机译：本发明涉及治疗患有代谢综合症，2型糖尿病，肥胖或前驱糖尿病的患者的方法，该方法包括增加中枢神经系统特别是下丘脑内多巴胺能神经元与去甲肾上腺素能神经元活性的比例的步骤。患者的中枢神经系统。

著录项

公开/公告号CA2688035A1

专利类型
公开/公告日2008-12-11

原文格式PDF
申请/专利权人 VEROSCIENCE LLC;
展开▼

申请/专利号CA20082688035
发明设计人 CINCOTTA ANTHONY H.;
展开▼

申请日2008-05-29
分类号A61K31/495;A61K31/13;A61K31/16;A61K31/4164;A61K31/425;A61K31/435;A61K31/46;A61K31/48;A61K31/55;A61K38/16;A61K45/06;A61P3;
国家 CA
入库时间 2022-08-21 19:23:10

相似文献

专利
外文文献
中文文献